The first patient has been dosed in a Phase 2 trial testing an all-oral, triple-combination treatment that includes Cellcentric’s investigational therapy inobrodib in people…
Latest news & perspectives
Discussion
A few weeks ago, I wrote about the annual challenge I face during the season of Lent: the temptation of Thin Mints. The Thin…
Caris Life Sciences has developed a genetic test that aims to simplify care for people with a group of blood cancers known as…
